MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer
- Department of Obstetrics & Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing (China)
- MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing (China)
Highlights: • Ovarian cancer (OC) has poor prognosis, due to recurrence and drug resistance. • Immune therapies using antigen-pulsed dendritic cells (DCs) are promising options. • Chloride intracellular channel 1 (CLIC1) is an OC biomarker with low antigenicity. • DCs were pulsed with a CLIC1/M. tuberculosis HSP70 (MtHsp70-CLIC1) fusion protein. • MtHsp70-CLIC1 showed significant anticancer effects in vitro and in vivo. Approximately 80% of ovarian cancer (OC) is diagnosed at late stages, and most patients die within 5 years of diagnosis due to recurrence or drug resistance. Novel treatments are required to improve patient survival. Immune therapy against cancer is promising; however, therapeutic vaccination has been limited by the inability of tumor antigens to induce effective immune responses. Chloride intracellular channel 1 (CLIC1) was previously identified as a possible tumor marker for OC. In this study, we constructed a recombinant protein by conjugating the extracellular domain of CLIC1 to the carboxyl terminus of Mycobacterium tuberculosis heat shock protein 70 (MtHsp70). Human dendritic cells (DCs) derived from cortical blood were pulsed with the fusion protein, and the antitumor effect of human cytotoxic T lymphocytes (CTLs) stimulated by autologous DCs was assessed in NOG mice. MtHsp70-CLIC1 promoted the phenotypic maturation of human DCs and the secretion of Th1-associated cytokines in vitro. MtHsp70-CLIC1-stimulated CTLs generated a CLIC1-specific immune response both in vitro and in vivo. These results indicate that DCs pulsed with MtHsp70-CLIC1 can enhance antitumor immunity against OC, providing a novel immune therapeutic strategy.
- OSTI ID:
- 22897524
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 494, Issue 1-2; Other Information: Copyright (c) 2017 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Chloroquine Engages the Immune System to Eradicate Irradiated Breast Tumors in Mice
TH-C-17A-11: Hyperthermia-Driven Immunotherapy Using Non-Invasive Radiowaves